World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Stojsavljević S, Gomerčić Palčić M, Virović Jukić L, Smirčić Duvnjak L, Duvnjak M. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(48): 18070-18091 [PMID: 25561778 DOI: 10.3748/wjg.v20.i48.18070]
URL:	https://www.wjgnet.com/1007-9327/full/v20/i48/18070.htm

(525) (412) (0) (0) (0) (17317) (283)

Number	Citing Articles
1	Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D. Byrne, Dan-Qin Sun, Ming-Hua Zheng. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nature Reviews Nephrology 2022; 18(4) doi: 10.1038/s41581-021-00519-y
2	Sandra Andreotti, Ayumi Cristina Medeiros Komino, Flaviane de Fatima Silva, Ana Paula Almeida Ramos, Noemi Lourenço Gil, Gabriela Araujo Azevedo, Rogerio Antonio Laurato Sertié, Fabio Bessa Lima, Richardt Gama Landgraf, Maristella Almeida Landgraf. Intrauterine food restriction impairs the lipogenesis process in the mesenteric adipocytes from low-birth-weight rats into adulthood. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1259854
3	Shui-Xian Du, Lin-Lin Lu, Yang Liu, Quan-Jiang Dong, Shi-Ying Xuan, Yong-Ning Xin. Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population. Hepatitis Monthly 2016; 16(7) doi: 10.5812/hepatmon.37388
4	Huashan Li, Jianying Sheng, Jing Wang, Haiting Gao, Jing Yu, Guoxian Ding, Ning Ding, Weiqi He, Juanmin Zha. Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice. Drug Design, Development and Therapy 2021; doi: 10.2147/DDDT.S285828
5	Lorena Bavia, Bruno Cogliati, Juliano Bertollo Dettoni, Venancio Avancini Ferreira Alves, Lourdes Isaac. The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model. Immunology Letters 2016; 177 doi: 10.1016/j.imlet.2016.07.014
6	Yi Wu, Ying Lin, Shan Xu, Dan Su, Hao Yang, Lidan Tang. Mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experiments. Open Medicine 2025; 20(1) doi: 10.1515/med-2025-1215
7	Cemal Nuri Ercin, Teoman Dogru, Halil Genc, Gurkan Celebi, Fatih Aslan, Hasan Gurel, Muammer Kara, Erdim Sertoglu, Serkan Tapan, Sait Bagci, Manfredi Rizzo, Alper Sonmez. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2015; 13(7) doi: 10.1089/met.2015.0018
8	Shigeru Murakami, Ayuko Ono, Azusa Kawasaki, Takaaki Takenaga, Takashi Ito. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. Amino Acids 2018; 50(9) doi: 10.1007/s00726-018-2605-8
9	Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease. Inflammation Research 2020; 69(9) doi: 10.1007/s00011-020-01373-7
10	Touraj Mahmoudi, Donya Ghorbani, Gholamreza Rezamand, Niloufar Dehestan, Golnaz Jeddi, Asadollah Asadi, Hossein Nobakht, Reza Dabiri, Hamid Farahani, Seidamir Pasha Tabaeian, Mohammad Reza Zali. A Visfatin Gene Promoter Polymorphism (Rs1319501) is Associated With Susceptibility to Nonalcoholic Fatty Liver Disease. Personalized Medicine 2023; 20(2) doi: 10.2217/pme-2022-0100
11	Jesus E. Maldonado-Arvizu, Paula Vanessa Rios-Verdugo, José Fernando Díaz-Villanueva, Brenda Chimal-Vega, José L. Vique-Sánchez, Victor García-González. The transition from preclinical to clinical obesity: the importance of a borderline stage. Clinical Science 2026; 140(1) doi: 10.1042/CS20256728
12	Karen R. Jonscher, Robert B. Rucker. Dietary Interventions in Liver Disease. 2019; doi: 10.1016/B978-0-12-814466-4.00013-6
13	Silvano Junior Santini, Cristiana Porcu, Giovanni Tarantino, Fernanda Amicarelli, Clara Balsano. Oleuropein overrides liver damage in steatotic mice. Journal of Functional Foods 2020; 65 doi: 10.1016/j.jff.2019.103756
14	Asad Mirzaei, Asma Asal, Ali Seidkhani-Nahal, Ali Noori-Zadeh. A systematic review and meta-analysis of serum resistin level and its relation to HOMA-IR score using meta-regression in nonalcoholic fatty liver disease patients. Mediterranean Journal of Nutrition and Metabolism 2021; 14(3) doi: 10.3233/MNM-210538
15	Obesity and Breast Cancer: Molecular and Epidemiological Evidence. Journal of Cancer Research Updates 2015; 4(1) doi: 10.6000/1929-2279.2015.04.01.3
16	. 2020; doi: 10.70675/a3d3dfefzd83dz4502zb987z5b0a8fe8cff5
17	Noha El Nakeeb, Shereen A Saleh, Yasmine M Massoud, Ahmed Hussein, Rana Hamed. Serum ferritin as a non‐invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non‐alcoholic fatty liver disease. JGH Open 2017; 1(3) doi: 10.1002/jgh3.12019
18	Antonio Olveira, Pedro Herranz, María Luisa Montes. Psoriasis and fatty liver: a harmful synergy. Revista Española de Enfermedades Digestivas 2019; 111 doi: 10.17235/reed.2019.6263/2019
19	Ai‐rong Zhang, Jing Sun, Yuan He, Ning Wang, Li Tian. Attenuation of lipid accumulation in Bel‐7402 cells through ADPN/AMPKα signaling stimulated by Fructus rosae laxae extract. Journal of Food Biochemistry 2020; 44(12) doi: 10.1111/jfbc.13497
20	Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice. Hepatology 2018; 68(5) doi: 10.1002/hep.30066
21	Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease. Chinese Journal of Integrative Medicine 2022; 28(6) doi: 10.1007/s11655-022-3307-3
22	Hormonal Regulation in Obesity: The Dose-dependent Impact of <i>Artocarpus altilis</i> Extract on Ghrelin, Leptin, and Adiponectin. Journal of Natural Remedies 2025; doi: 10.18311/jnr/2025/47615
23	Abdelghany Hassan Abdelghany, Mohammad A. BaSalamah, Shakir Idris, Jawwad Ahmad, Bassem Refaat. The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in rats. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1040-4
24	Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases 2022; 14(2) doi: 10.34172/mejdd.2022.270
25	Lucia Dansero, Lorenzo Milani, Carlotta Sacerdote, Pietro Ferrari, Mazda Jenab, Fulvio Ricceri. Exploring the Syndemic of Steatotic Liver Disease, Socioeconomic Inequities and Cancer Risk in the UK Biobank. Liver International 2026; 46(1) doi: 10.1111/liv.70458
26	Ji Eun Heo, Dong Gyun Kim, Jeong Woo Yoo, Kwang Suk Lee. Metabolic syndrome-related factors as possible targets for lower urinary tract symptoms in Korean males. The Aging Male 2023; 26(1) doi: 10.1080/13685538.2023.2166920
27	Darmadi Darmadi, Riska Habriel Ruslie. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). Romanian Journal of Internal Medicine 2021; 59(1) doi: 10.2478/rjim-2020-0029
28	. 2015; doi: 10.70675/5d5494f1z0246z46b7z8182z06138ded37a2
29	Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053 Abstract(2343) \| Core Tip(1847) \| Full Article(HTML)(23573) \| Full Article (PDF)-1307K(1715) \| Full Article (Word)-540K(558) \| Peer-Review Report-156K(510) \| Answering Reviewers-62K(562) \| Times Cited (77) \| Total Visits (26522) \| Open
30	Sara Raia, Antonio Conti, Alan Zanardi, Barbara Ferrini, Giulia Maria Scotti, Enrica Gilberti, Giuseppe De Palma, Samuel David, Massimo Alessio. Ceruloplasmin-Deficient Mice Show Dysregulation of Lipid Metabolism in Liver and Adipose Tissue Reduced by a Protein Replacement. International Journal of Molecular Sciences 2023; 24(2) doi: 10.3390/ijms24021150
31	Noha F. Hassan, Azza H. Hassan, Mona R. El-Ansary. Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose diet. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24593-9
32	Smitha Krishnan, Yufang Ding, Nima Saedi, Maria Choi, Gautham V. Sridharan, David H. Sherr, Martin L. Yarmush, Robert C. Alaniz, Arul Jayaraman, Kyongbum Lee. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages. Cell Reports 2018; 23(4) doi: 10.1016/j.celrep.2018.03.109
33	Jun-Qi Shi, Wen-Xia Shen, Xiang-Zhi Wang, Ke Huang, Chao-Chun Zou. Relationship between immune parameters and non-alcoholic fatty liver disease in obese children. Indian Pediatrics 2017; 54(10) doi: 10.1007/s13312-017-1143-x
34	Aoife N. O’Donovan, Florence M. Herisson, Fiona Fouhy, Paul M. Ryan, Derek Whelan, Crystal N. Johnson, Gaston Cluzel, R. Paul Ross, Catherine Stanton, Noel M. Caplice. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. American Journal of Physiology-Heart and Circulatory Physiology 2020; 318(3) doi: 10.1152/ajpheart.00512.2019
35	Ayokanmi Ore, Oluseyi Adeboye Akinloye. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. Medicina 2021; 57(8) doi: 10.3390/medicina57080822
36	Charalampos G. Pontikoglou, Theodosios D. Filippatos, Angelos Matheakakis, Helen A. Papadaki. Steatotic liver disease in the context of hematological malignancies and anti-neoplastic chemotherapy. Metabolism 2024; 160 doi: 10.1016/j.metabol.2024.156000
37	Adriano Lama, Claudio Pirozzi, Maria Pia Mollica, Giovanna Trinchese, Francesca Di Guida, Gina Cavaliere, Antonio Calignano, Giuseppina Mattace Raso, Roberto Berni Canani, Rosaria Meli. Polyphenol‐rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high‐fat diet fed rats. Molecular Nutrition & Food Research 2017; 61(3) doi: 10.1002/mnfr.201600418
38	Liyun Xu, Wen Liu, Fuxiang Bai, Yong Xu, Xiaohong Liang, Chunhong Ma, Lifen Gao. Hepatic Macrophage as a Key Player in Fatty Liver Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.708978
39	Roberta Gasparro, Giuditta Gambino, Giulia Duca, Danila Di Majo, Valentina Di Liberto, Vincenza Tinnirello, Giulia Urone, Nicolò Ricciardi, Monica Frinchi, Nima Rabienezhad Ganji, Giuseppe Vergilio, Francesco Paolo Zummo, Francesca Rappa, Simona Fontana, Alice Conigliaro, Pierangelo Sardo, Giuseppe Ferraro, Riccardo Alessandro, Stefania Raimondo. Protective effects of lemon nanovesicles: evidence of the Nrf2/HO-1 pathway contribution from in vitro hepatocytes and in vivo high-fat diet-fed rats. Biomedicine & Pharmacotherapy 2024; 180 doi: 10.1016/j.biopha.2024.117532
40	Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Jun Kato, Shiho Tokunaga, Taka-aki Sugihara, Yuichi Hara, Keisuke Hino, Yoshikazu Murawaki, Gonzalo Carrasco-Avino. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. PLOS ONE 2016; 11(5) doi: 10.1371/journal.pone.0154676
41	Lingling Ding, Toon. J. I. De Munck, Yvonne Oligschlaeger, Inês Magro dos Reis, Jef Verbeek, Ger. H. Koek, Tom Houben, Ronit Shiri-Sverdlov. Myosteatosis in NAFLD patients correlates with plasma Cathepsin D. Biomolecular Concepts 2021; 12(1) doi: 10.1515/bmc-2021-0004
42	Xin Du, Jingwei Li. Analysis of the Mediating Role of Cytokines in the Relationship Between Nonalcoholic Fatty Liver Disease and Cognitive Impairment After Ischemic Stroke. Brain and Behavior 2026; 16(10) doi: 10.1002/brb3.71725
43	Ying-Li Liu, Qiu-Zan Zhang, Yan-Rong Wang, Li-Na Fu, Jing-Shu Han, Jing Zhang, Bang-Mao Wang. Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.605064
44	Xiaojing Wang, Lan Li, Hongwu Wang, Fang Xiao, Qin Ning. Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet–induced non‐alcoholic steatohepatitis in mice. Scandinavian Journal of Immunology 2019; 90(3) doi: 10.1111/sji.12791
45	Jingyi Guo, Shangyi Huang, Qincheng Yi, Naihua Liu, Tianqi Cui, Siwei Duan, Jiabing Chen, Jiayu Li, Jun Li, Lei Wang, Yong Gao, Guangning Nie. Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR. ACS Omega 2023; 8(29) doi: 10.1021/acsomega.3c02347
46	Daqing Zhang, Zhen Mi, Jiya Peng, Tiangui Yang, Yuze Han, Yujia Zhai, Chenliang Song, Xianzhuo Teng, Wei Sun, Jing Guo, Kabeya Paulin Bilonda. Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular Diseases. Journal of Cardiovascular Pharmacology 2023; 81(5) doi: 10.1097/FJC.0000000000001418
47	Ji-Young Cha, Da-Hyun Kim, Kyung-Hee Chun. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Laboratory Animal Research 2018; 34(4) doi: 10.5625/lar.2018.34.4.133
48	Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson. NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?. Current HIV/AIDS Reports 2018; 15(3) doi: 10.1007/s11904-018-0392-1
49	Daniel Costache, Horia Blejan, Damian Cojocaru, Georgiana Ioniță, Marcela Poenaru, Maria Constantin, Andrei Costache, Constantin Căruntu, Daniel Balaban, Raluca Costache. Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet—A Comprehensive Review. International Journal of Molecular Sciences 2024; 25(5) doi: 10.3390/ijms25052660
50	Oliver Glass, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing‐Kin Syn, Cynthia A. Moylan, Robert Streilein, Russell Hall, Anna Mae Diehl, Manal F. Abdelmalek. Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatology Communications 2018; 2(11) doi: 10.1002/hep4.1237
51	Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; doi: 10.1016/B978-0-323-37591-7.00025-2
52	Georgia Bale, Frédéric Clarembeau, Peter Stärkel, Géraldine Dahlqvist, Yves Horsmans, Nicolas Lanthier. Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(8) doi: 10.1016/j.clinre.2024.102428
53	Cheng‐Chung Li, Chun Liu, Maobin Fu, Kang‐Quan Hu, Koichi Aizawa, Shingo Takahashi, Suganuma Hiroyuki, Junrui Cheng, Johannes von Lintig, Xiang‐Dong Wang. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. Molecular Nutrition & Food Research 2018; 62(8) doi: 10.1002/mnfr.201700738
54	Markos Kalligeros, Linda Henry, Zobair M. Younossi. Metabolic dysfunction-associated steatotic liver disease and its link to cancer. Metabolism 2024; 160 doi: 10.1016/j.metabol.2024.156004
55	Kimia Mohammadhasani, Mohammad Vahedi Fard, Ali Mottaghi Moghaddam Shahri, Zahra Khorasanchi. Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review. Food Science & Nutrition 2024; 12(8) doi: 10.1002/fsn3.4178
56	Silvia M. Ferolla. Obesity. 2016; doi: 10.1007/978-3-319-19821-7_13
57	Minghui Zheng, Jing Li, Weizhen Fang, Ling Luo, Rui Ding, Hua Zeng, Hong Luo, Xianghua Lin, Chaohui Duan. The TNF-α rs361525 and IFN-γ rs2430561 polymorphisms are associated with liver cirrhosis risk: a comprehensive meta-analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1129767
58	Amirhossein Tamimi, Mona Javid, Nasrin Sedighi-Pirsaraei, Arian Mirdamadi. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1420281
59	Hee Jae Lee, Yunsook Lim, Soo Jin Yang. Involvement of resveratrol in crosstalk between adipokine adiponectin and hepatokine fetuin-A in vivo and in vitro. The Journal of Nutritional Biochemistry 2015; 26(11) doi: 10.1016/j.jnutbio.2015.06.001
60	M. A. Livzan, T. S. Krolevets, S. I. Mozgovoy, N. A. Nikolaev, A. V. Nelidova. Features of intestinal microbiota disorders in the development of metabolic disorders in non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2021; 93(2) doi: 10.26442/00403660.2021.02.200614
61	Gamal A. Salem, Amany Abdel-Rahman Mohamed, Safaa I. Khater, Ahmed E. Noreldin, Manal Alosaimi, Wafa S. Alansari, Ghalia Shamlan, Areej A. Eskandrani, Marwa Mahmoud Awad, Rehab Ahmed Ahmed El-Shaer, Mohamed A. Nassan, Mahmoud Mostafa, Tarek Khamis. Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes. Gene 2023; 883 doi: 10.1016/j.gene.2023.147670
62	Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2) doi: 10.14218/JCTH.2021.00268
63	Magdalena Losko, Jerzy Kotlinowski, Jolanta Jura. Long Noncoding RNAs in Metabolic Syndrome Related Disorders. Mediators of Inflammation 2016; 2016 doi: 10.1155/2016/5365209
64	Alaa M. Mostafa, Yasser Fouad, Mohamed AbdAllah, Doaa Abdeltawab, Ziyan Pan, Mohammed Eslam. Metabolic dysfunction–associated fatty liver disease increases the risk of sleep abnormalities: an analysis of the National Health and Nutrition Examination Survey 2017–2020. European Journal of Gastroenterology & Hepatology 2026; 38(6) doi: 10.1097/MEG.0000000000003123
65	Jing Xiong, Xia Chen, Zhijing Zhao, Ying Liao, Ting Zhou, Qian Xiang. A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective study. Experimental and Therapeutic Medicine 2022; 24(3) doi: 10.3892/etm.2022.11536
66	Emilia Gore, Emilia Bigaeva, Anouk Oldenburger, Yvette J. M. Jansen, Detlef Schuppan, Miriam Boersema, Jörg F. Rippmann, Andre Broermann, Peter Olinga. Investigating fibrosis and inflammation in an ex vivo NASH murine model. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(2) doi: 10.1152/ajpgi.00209.2019
67	Huicun Zhang, Xiang Gao, Pengmin Chen, Hongbing Wang. Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.851267
68	Ye Rim Nam, Sae Bom Won, Young-Shin Chung, Chung Shil Kwak, Young Hye Kwon. Inhibitory effects ofDoenjang, Korean traditional fermented soybean paste, on oxidative stress and inflammation in adipose tissue of mice fed a high-fat diet. Nutrition Research and Practice 2015; 9(3) doi: 10.4162/nrp.2015.9.3.235
69	M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; doi: 10.1016/B978-0-12-812504-5.00006-4
70	Toshio Nishi, Yuta Yamamoto, Naoko Yamagishi, Mikitaka Iguchi, Hideyuki Tamai, Takao Ito, Yoshihiro Tsuruo, Masao Ichinose, Masayuki Kitano, Takashi Ueyama. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. Journal of Pharmacy and Pharmacology 2018; 70(3) doi: 10.1111/jphp.12870
71	Chifa Ma, Yiwen Liu, Shuli He, Jingbo Zeng, Pingping Li, Chunxiao Ma, Fan Ping, Huabing Zhang, Lingling Xu, Wei Li, Yuxiu Li. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.600472
72	Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Boram Park, Seong Joon An, Joo Sung Kim. Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia. Journal of Korean Medical Science 2020; 35(22) doi: 10.3346/jkms.2020.35.e164
73	. Advances in Clinical Chemistry 2017; 79 doi: 10.1016/bs.acc.2016.10.002
74	Eunhui Seo, Yoon Sin Oh, Hee-Sook Jun. Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice. Nutrients 2016; 8(2) doi: 10.3390/nu8020083
75	Viviana Casagrande, Alessandro Mauriello, Simone Bischetti, Maria Mavilio, Massimo Federici, Rossella Menghini. Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06439-x
76	Ioana Corina Bocsan, Mircea Vasile Milaciu, Raluca Maria Pop, Stefan Cristian Vesa, Lorena Ciumarnean, Daniela Maria Matei, Anca Dana Buzoianu, Giuseppe Valacchi. Cytokines Genotype‐Phenotype Correlation in Nonalcoholic Steatohepatitis. Oxidative Medicine and Cellular Longevity 2017; 2017(1) doi: 10.1155/2017/4297206
77	Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang. Blood-Based Novel Biomarkers for Nonalcoholic Steatohepatitis. Biomarkers in Medicine 2018; 12(5) doi: 10.2217/bmm-2017-0361
78	Mirella Pastore, Alessandra Gentilini, Fabio Marra. Non-Alcoholic Fatty Liver Disease. 2020; doi: 10.1007/978-3-319-95828-6_6
79	Chieh Chen. The role of adipokines in the disease of metabolic-associated fatty liver disease. Tungs' Medical Journal 2023; 17(2) doi: 10.4103/ETMJ.ETMJ-D-23-00015
80	Young Hwan Jang, Dong Hyun In, Jae Kook Yang, Hyuk Jin Moon, Gyu Tae Yoon, Ah Jeong Ryu, Yeo Joo Kim, Eun Young Lee, Hyun Jin Kim, Bon Jeong Ku, Jae Min Lee, Kang Seo Park, In Suk Lee, Jong Min Lee, Dong Mee Lim, Keun Yong Park, Sang Jin Kim. The Effect of Vildagliptin on Visfatin in Korean Patients with Type 2 Diabetes: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Prospective Study. The Journal of Korean Diabetes 2015; 16(4) doi: 10.4093/jkd.2015.16.4.303
81	Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006 Abstract(2096) \| Core Tip(2559) \| Full Article(HTML)(13686) \| Full Article (PDF)-1227K(1352) \| Full Article (Word)-299K(471) \| Audio-1029K(78) \| Peer-Review Report-83K(378) \| Answering Reviewers-68K(536) \| Times Cited (138) \| Total Visits (16150) \| Open
82	Yu-Lin Chao, Pei-Yu Wu, Jiun-Chi Huang, Yi-Wen Chiu, Jia-Jung Lee, Szu-Chia Chen, Jer-Ming Chang, Shang-Jyh Hwang, Hung-Chun Chen. Hepatic Steatosis Is Associated with High White Blood Cell and Platelet Counts. Biomedicines 2022; 10(4) doi: 10.3390/biomedicines10040892
83	Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obesity Reviews 2019; 20(7) doi: 10.1111/obr.12853
84	Carmelo Luci, Elodie Vieira, Thibaut Perchet, Philippe Gual, Rachel Golub. Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01192
85	Wen Liu, Fuxiang Bai, Hongxing Wang, Yan Liang, Xianhong Du, Cui Liu, Dejian Cai, Jiali Peng, Guangming Zhong, Xiaohong Liang, Chunhong Ma, Lifen Gao. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages. The Journal of Immunology 2019; 203(4) doi: 10.4049/jimmunol.1900117
86	Monica Dinu, Anne Whittaker, Giuditta Pagliai, Ilaria Giangrandi, Barbara Colombini, Anna Maria Gori, Claudia Fiorillo, Matteo Becatti, Alessandro Casini, Stefano Benedettelli, Francesco Sofi. A Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical Trial. Journal of the American College of Nutrition 2018; 37(6) doi: 10.1080/07315724.2018.1445047
87	Shunqin Wang, Jingsong Liu, Junfeng Zhang, Jiancheng Lin, Shuyu Yang, Jiangwu Yao, Minquan Du. Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitis. Brazilian Oral Research 2017; 31(0) doi: 10.1590/1807-3107bor-2017.vol31.0090
88	Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11) doi: 10.3390/nu11112586
89	Emilio Molina‐Molina, Guilherme Eustaquio. Furtado, John G. Jones, Piero Portincasa, Ana Vieira‐Pedrosa, Ana Maria Teixeira, Marcelo Paes Barros, André Luís Lacerda Bachi, Vilma A. Sardão. The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women. European Journal of Clinical Investigation 2022; 52(3) doi: 10.1111/eci.13731
90	Fan Zhang, Wenjian Li. Impact of fatty liver index and metabolic dysfunction-associated steatotic liver disease on the risk of benign prostatic hyperplasia in older male adults. BMC Geriatrics 2025; 25(1) doi: 10.1186/s12877-025-06314-9
91	Ruixiang Cui, Honglin Sun, Mengge Yang, Ying Wang, Jia Liu, Guang Wang. The Nonlinear Association Between Adipose Tissue Insulin Resistance and Remnant Cholesterol in Chinese Adults: A Cross-Sectional Study. Journal of Cardiovascular Development and Disease 2026; 13(9) doi: 10.3390/jcdd13090459
92	Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2016.05.003
93	Mohammad Moradzad, Mohammad Raman Moloudi, Alina Abdollahi, Shohreh Fakhari, Zakaria Vahabzadeh. TMAO promotes metabolic dysfunction-associated fatty liver disease (MAFLD) development through long-non coding RNA- highly upregulated liver cancer (HULC). Journal of Diabetes & Metabolic Disorders 2025; 24(1) doi: 10.1007/s40200-025-01605-9
94	Xing-Yu Luo, Wei-Bin Huang, Chuang-Hui Lu, Wu Gu, Zi-Xuan Feng, Sui Shen, Ming-Zheng Chen, Shu-Sen Zheng, Zhe Yang. Application of probiotic therapy in nonalcoholic fatty liver disease: mediating mechanism and future perspective. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1638372
95	Jari E. Kaikkonen, Petri Kresanov, Markku Ahotupa, Antti Jula, Vera Mikkilä, Jorma S. A. Viikari, Markus Juonala, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Antti J. Kangas, Pasi Soininen, Mika Ala-Korpela, Olli T. Raitakari. Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the Cardiovascular Risk in Young Finns Study. Free Radical Research 2016; 50(4) doi: 10.3109/10715762.2015.1133906
96	Roya Navekar, Maryam Rafraf, Aida Ghaffari, Mohammad Asghari-Jafarabadi, Manouchehr Khoshbaten. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. Journal of the American College of Nutrition 2017; 36(4) doi: 10.1080/07315724.2016.1267597
97	Johannes Sollner. Vaccine Design. Methods in Molecular Biology 2016; 1403 doi: 10.1007/978-1-4939-3387-7_5
98	The effect of complex treatment of patients with non-alcoholic steatohepatitis in combination with type 2 diabetes on the course of the inflammatory process: adiponectin and proinflammatory cytokines. Family medicine 2018; (3) doi: 10.30841/2307-5112.3.2018.146359
99	V.B. Yagmur, L.V. Demeshkina, S.L. Melanich, R.M. Kyslova. Influence of age, body mass index and gender on sonographic indicators of the liver in patients with metabolic dysfunction-associated steatotic liver disease. GASTROENTEROLOGY 2024; 58(2) doi: 10.22141/2308-2097.58.2.2024.604
100	Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. Inflammation 2019; 42(3) doi: 10.1007/s10753-019-00967-6
101	Sara Parrettini, Massimiliano Cavallo, Francesco Gaggia, Riccardo Calafiore, Giovanni Luca. Adipokines: A Rainbow of Proteins with Metabolic and Endocrine Functions. Protein & Peptide Letters 2020; 27(12) doi: 10.2174/0929866527666200505214555
102	Yuling Xing, Jinhu Chen, Jing Liu, Guangyao Song, Huijuan Ma. Relationship Between Serum Uric Acid-to-Creatinine Ratio and the Risk of Metabolic-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; doi: 10.2147/DMSO.S350468
103	H Hen, Y Tang, L Zhuang, Y Zheng, X Huang. PINK1/Park2-Mediated Mitophagy Relieve Non-Alcoholic Fatty Liver Disease. Physiological Research 2024; doi: 10.33549/physiolres.934925
104	Qian Wang, Dehai Li, Jing Zhu, Mingyue Zhang, Hua Zhang, Guangchao Cao, Leqing Zhu, Qiping Shi, Jianlei Hao, Qiong Wen, Zonghua Liu, Hengwen Yang, Zhinan Yin. Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLD. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00846
105	Van Dan Castro-Gerónimo, Alberto Sánchez-Medina, Germán Alberto Chamorro-Cevallos, Candelaria Galván-Colorado, Israel Ramírez-Sánchez, Enrique Méndez-Bolaina, Rosa Virginia García-Rodríguez. Cardioprotective and Antihyperlipidemic Effects of Arthrospira maxima Phycobiliproteins in a Prediabetic Rat Model of Acute Myocardial Infarction. ACS Omega 2025; 10(41) doi: 10.1021/acsomega.5c05120
106	Kun Tang, Fei Wang, Yi Zeng, XueMeng Chen, XiaoLe Xu. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice. European Journal of Pharmacology 2018; 830 doi: 10.1016/j.ejphar.2018.04.026
107	Diana Zamosteanu, Nina Filip, Ludmila Lozneanu, Simona Eliza Giusca, Oana Viola Badulescu, Mihaela Pertea, Alexandru Filip, Carmen Ungureanu, Eugenia Morosan, Elena Cojocaru. Amino Acids—Potential Biomarkers of Histological Features for MASLD in Pediatric Obesity. International Journal of Molecular Sciences 2026; 27(8) doi: 10.3390/ijms27083596
108	Petra Surlin, Andreea Cristiana Didilescu, Luminita Lazar, Cristian Cosmin Arsenie, Adrian Camen, Dora Maria Popescu, Dorin Nicolae Gheorghe, Eugen Osiac, Ion Rogoveanu. Evaluation Through the Optical Coherence Tomography Analysis of the Influence of Non-Alcoholic Fatty Liver Disease on the Gingival Inflammation in Periodontal Patients. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; doi: 10.2147/DMSO.S310314
109	Md Monirujjaman, Oliver F. Bathe, Vera C. Mazurak. Dietary EPA+DHA Mitigate Hepatic Toxicity and Modify the Oxylipin Profile in an Animal Model of Colorectal Cancer Treated with Chemotherapy. Cancers 2022; 14(22) doi: 10.3390/cancers14225703
110	Rozita Khodashahi, Mohsen Aliakbarian, Gordon A Ferns, Mohammad-Hassan Arjmand. The Association between Circulating Adipocytokine Omentin Levels and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Current Molecular Medicine 2024; 24(11) doi: 10.2174/1566524023666230913105910
111	Wen-Chung Huang, Po-Chen Liao, Chun-Hsun Huang, Sindy Hu, Shih-Chun Huang, Shu-Ju Wu. Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cells. Biomedicine & Pharmacotherapy 2017; 91 doi: 10.1016/j.biopha.2017.04.051
112	Lauren Barron, Cathleen Courtney, James Bao, Emily Onufer, Roheena Z. Panni, Bola Aladegbami, Brad W. Warner. Intestinal resection-associated metabolic syndrome. Journal of Pediatric Surgery 2018; 53(6) doi: 10.1016/j.jpedsurg.2018.02.077
113	Panagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis. Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations. World Journal of Gastroenterology 2022; 28(39): 5691-5706 doi: 10.3748/wjg.v28.i39.5691 Abstract(1445) \| Core Tip(1069) \| Full Article(HTML)(8198) \| Full Article (PDF)-3923K(742) \| Full Article (Word)-361K(105) \| Audio-920K(32) \| Peer-Review Report-414K(231) \| Answering Reviewers-308K(205) \| Times Cited (33) \| Total Visits (10794) \| Open
114	Evelyn Nunes Goulart da Silva Pereira, Beatriz Peres de Araujo, Karine Lino Rodrigues, Raquel Rangel Silvares, Carolina Souza Machado Martins, Edgar Eduardo Ilaquita Flores, Caroline Fernandes-Santos, Anissa Daliry. Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress. Nutrients 2022; 14(3) doi: 10.3390/nu14030716
115	Hon-Jhe Chen, Hao-Yu Yang, Kuang-Chieh Hsueh, Cheng-Che Shen, Ru-Yi Chen, Hsien-Chung Yu, Tzu-Lin Wang. Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease. Medicine 2018; 97(42) doi: 10.1097/MD.0000000000012835
116	Lili Chen, Xiaolong Zhao, Guangjun Liang, Jiuru Sun, Zhifeng Lin, Renming Hu, Peili Chen, Zhaoyun Zhang, Linuo Zhou, Yiming Li. Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitis. Nutrition & Metabolism 2017; 14(1) doi: 10.1186/s12986-017-0208-0
117	Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Seyed Ali Malek-Hosseini. Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis. United European Gastroenterology Journal 2018; 6(1) doi: 10.1177/2050640617707863
118	Montgomery Blencowe, Tilan Karunanayake, Julian Wier, Neil Hsu, Xia Yang. Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease. Genes 2019; 10(12) doi: 10.3390/genes10120966
119	Alice Yuxin Wang, Jasbir Dhaliwal, Marialena Mouzaki. Lean non-alcoholic fatty liver disease. Clinical Nutrition 2019; 38(3) doi: 10.1016/j.clnu.2018.08.008
120	Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Adipokines in nonalcoholic fatty liver disease. Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2015.11.006
121	Sangam Rajak. Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(4) doi: 10.1016/j.bbadis.2024.167102
122	Maja Cigrovski Berkovic, Lucija Virovic-Jukic, Ines Bilic-Curcic, Anna Mrzljak. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management. World Journal of Gastroenterology 2020; 26(21): 2740-2757 doi: 10.3748/wjg.v26.i21.2740 Abstract(1469) \| Core Tip(1457) \| Full Article(HTML)(9830) \| Full Article (PDF)-1722K(1256) \| Full Article (Word)-386K(266) \| Audio-280K(33) \| Peer-Review Report-237K(446) \| Answering Reviewers-99K(377) \| Times Cited (22) \| Total Visits (13422) \| Open
123	Shusong Wu, Ruizhi Hu, Hironobu Nakano, Keyu Chen, Ming Liu, Xi He, Hongfu Zhang, Jianhua He, De-Xing Hou. Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet. Molecules 2018; 23(12) doi: 10.3390/molecules23123213
124	Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(11) doi: 10.3390/ijms21114189
125	Jinjin Li, Jialin Li, Jiajia Ni, Caibo Zhang, Jianlei Jia, Guoying Wu, Hongzhao Sun, Shuzhen Wang. Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut Microbiota. Frontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.752512
126	Youzhao Jiang, Liu Chen, Hui Wang, Bao Narisi, Bing Chen. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress. Journal of Ethnopharmacology 2015; 176 doi: 10.1016/j.jep.2015.11.019
127	Milton Packer. Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease. The American Journal of Medicine 2020; 133(2) doi: 10.1016/j.amjmed.2019.09.002
128	Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; doi: 10.1007/978-94-007-7675-3_37
129	Shankun Zhao, Yaoyao Wang, Weizhou Wu, Suqing Yang, Lili Feng, Fangfang Tao, Weiwei Ge, Maolei Shen, Weifang Xu. Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance. Andrologia 2021; 53(6) doi: 10.1111/and.14060
130	Magdalena Świderska, Mateusz Maciejczyk, Anna Zalewska, Joanna Pogorzelska, Robert Flisiak, Adrian Chabowski. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients. Free Radical Research 2019; 53(8) doi: 10.1080/10715762.2019.1635691
131	S. A. Pavlovskyi. EVALUATION OF CONTENT OF CITOKINS IN PATIENTS� BLOOD WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH DIABETES MELLITUS TYPE 2 UNDER THE INFLUENCE OF COMBINED SUCTIONAL THERAPY. Bulletin of Problems Biology and Medicine 2018; (144) doi: 10.29254/2077-4214-2018-1-2-143-170-175
132	Hossein Bahari, Mostafa Shahraki Jazinaki, Ladan Aghakhani, Alireza Hatami, Iman Rahnama, Mahsa Malekahmadi. Oleoylethanolamide supplementation on cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1553288
133	Yilizere Aibaidula, Mutalifu Aimaiti, Huiwen Tan, Bingting Chen, Jian Yang, Xiaoli Ma. Lactucin & Lactucopicrin ameliorates FFA-induced steatosis in HepG2 cells via modulating lipid metabolism. Journal of Pharmacological Sciences 2022; 150(2) doi: 10.1016/j.jphs.2022.07.007
134	Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Eugeniusz Tarasów, Małgorzata Wojtkowska, Irena Białokoz-Kalinowska, Dariusz Marek Lebensztejn. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/3870454
135	R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?. British Journal of Dermatology 2018; 179(1) doi: 10.1111/bjd.16239
136	Song Wang, Jian Wang, Yajing Liu, Hui Li, Qiao Wang, Zhiwei Huang, Wenbin Liu, Ping Shi. Trivalent Chromium Supplementation Ameliorates Oleic Acid-Induced Hepatic Steatosis in Mice. Biological Trace Element Research 2019; 187(1) doi: 10.1007/s12011-018-1368-0
137	Badamgarav Bat-Erdene, Min He, Jingsong Dong, Ying Li, Dean Ta. Therapeutic Effects of Different Ultrasound Intensity Stimulation on Brown Adipose Tissue for the Treatment of Type 2 Diabetes. Ultrasound in Medicine & Biology 2025; 51(5) doi: 10.1016/j.ultrasmedbio.2025.01.010
138	Sanja Panic Zaric, Teofana-Otilia Bizerea-Moga, Rade Vukovic, Maja Janicijevic, Raluca Isac, Tudor Voicu Moga, Alina Popescu. Redox–Metabolic Crosstalk in Pediatric MASLD: Biomarkers, Mechanisms, and the Emerging Role of Selenium. International Journal of Molecular Sciences 2026; 27(17) doi: 10.3390/ijms27177575
139	A Al-Radaideh, R Tayyem, K Al-Fayomi, N Nimer, A Almomani, S Alhajjaj, L Agraib, N Hijjawi. The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imaging. British Journal of Biomedical Science 2019; 76(2) doi: 10.1080/09674845.2019.1571555
140	Mooli Raja Gopal Reddy, Malleswarapu Mahesh, Munikumar Manne, Uday Kumar Putcha, Shanmugam M. Jeyakumar. Vitamin A and its metabolic pathway play a determinant role in high‐fructose‐induced triglyceride accumulation of the visceral adipose depot of male Wistar rats. Cell Biochemistry and Function 2019; 37(8) doi: 10.1002/cbf.3434
141	Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar. A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals. Journal of Gastroenterology and Hepatology 2021; 36(6) doi: 10.1111/jgh.15353
142	María Gordito Soler, Ángel Arturo López-González, Daniela Vallejos, Emilio Martínez-Almoyna Rifá, María Teófila Vicente-Herrero, José Ignacio Ramírez-Manent. Usefulness of Body Fat and Visceral Fat Determined by Bioimpedanciometry versus Body Mass Index and Waist Circumference in Predicting Elevated Values of Different Risk Scales for Non-Alcoholic Fatty Liver Disease. Nutrients 2024; 16(13) doi: 10.3390/nu16132160
143	Ru Xun Foo, Jenny Junyi Ma, Ruochen Du, George Boon Bee Goh, Yap Seng Chong, Cuilin Zhang, Ling-Jun Li. Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysis. eClinicalMedicine 2024; 72 doi: 10.1016/j.eclinm.2024.102609
144	Emma Rose McGlone, Ahmed R. Ahmed. Global Bariatric Surgery. 2018; doi: 10.1007/978-3-319-93545-4_36
145	Hui Li, Mark J. Canet, John D. Clarke, Dean Billheimer, Stavra A. Xanthakos, Joel E. Lavine, Robert P. Erickson, Nathan J. Cherrington. Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition 2017; 45(12) doi: 10.1124/dmd.117.077644
146	George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou, George K. Koukoulis. NAFLD and autoimmune hepatitis: Do not judge a book by its cover. European Journal of Internal Medicine 2020; 75 doi: 10.1016/j.ejim.2020.02.001
147	Sumit Kar, Sabina Paglialunga, Sharon H. Jaycox, Rafiqul Islam, Angelo H. Paredes, Rohit Kohli. Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. PLOS ONE 2019; 14(7) doi: 10.1371/journal.pone.0217263
148	Johanna Heitmann, Verena G. Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan. Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021; 19(4) doi: 10.1111/ddg.14425
149	Susana Castro-Sánchez, Esteban Pérez-Giraldo, Juan Carlos Restrepo-Gutiérrez, Carlos E. Builes-Montaño. Enfermedad hepática grasa no alcohólica en personas no obesas: revisión narrativa de la literatura. Hepatología 2021; doi: 10.52784/27112330.129
150	Narges Damavandi, Sirous Zeinali. Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease. Molecular Biology Reports 2021; 48(2) doi: 10.1007/s11033-021-06142-1
151	Nadia Panera, Claudia Della Corte, Annalisa Crudele, Laura Stronati, Valerio Nobili, Anna Alisi. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines. Expert Review of Gastroenterology & Hepatology 2016; 10(3) doi: 10.1586/17474124.2016.1110485
152	Sifan Chen, Zhongliang Zhao, Liangru Ke, Zilun Li, Wenxue Li, Zili Zhang, Ying Zhou, Xiang Feng, Wei Zhu. Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1. The Journal of Nutritional Biochemistry 2018; 55 doi: 10.1016/j.jnutbio.2018.02.007
153	Marko Duvnjak, Sanja Stojsavljević, Lucija Virović Jukić, Lea Smirčić Duvnjak. Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLD. Journal of Clinical and Translational Hepatology 2019; 7(2) doi: 10.14218/JCTH.2019.00022
154	Simona Cernea, Andrada Larisa Roiban, Emőke Both, Adina Huţanu. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 2018; 34(8) doi: 10.1002/dmrr.3050
155	Claudia Calder�n‑Torres, Lirio Sarabia‑Curz, Yadira Ledesma‑Soto, Miguel Murgu�a‑Romero, Luis Terrazas‑Vald�s. Denitrase activity of Debaryomyces�hansenii reduces the oxidized compound 3‑nitrotyrosine in mice liver with colitis. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7395
156	Yanyan Xuan, Dingting Wu, Qi Yao. Fasting blood glucose to high-density lipoprotein cholesterol ratio and MASLD risk: non-linear association and BMI mediation in non-diabetic adults. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1818931
157	Qiwen Pang, Zhen Sun, Chen Shao, Honghua Cai, Zhengyang Bao, Lin Wang, Lihua Li, Lele Jing, Lili Zhang, Zhongqun Wang. CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.583943
158	. 2015; doi: 10.70675/0929c758z117az4932z8136z86adc06f8962
159	Rohith N. Thota, Jessica J. A. Ferguson, Kylie A. Abbott, Cintia B. Dias, Manohar L. Garg. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effectsvs. clinical outcomes. Food & Function 2018; 9(7) doi: 10.1039/C8FO00348C
160	Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2) doi: 10.26442/00403660.2022.02.201363
161	Doaa El Amrousy, Dalia El-Afify. Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease. Cytokine 2020; 135 doi: 10.1016/j.cyto.2020.155215
162	Layla Al-Mansoori, Asma A. Elashi, Laila Hedaya, Maha Alser, Shamma Almuraikhy, Najeha Anwardeen, Hend Al-Jaber, Suhad Hussain, Hamda A. Al-Naemi, Vijay Govindharajan, Rafif Mahmood Al-Saady, Mohammed Imad Malki, Khaled Naja, Mohamed A. Elrayess. GATA-3 Suppression by DNAzyme Modulates Interleukin-10 and Liver Injury Markers in db/db Mice. Biology 2025; 15(1) doi: 10.3390/biology15010089
163	Stavroula Kanoni, Satish Kumar, Charalampia Amerikanou, Mary Jo Kurth, Maria G. Stathopoulou, Stephane Bourgeois, Christine Masson, Aimo Kannt, Lucia Cesarini, Maria-Spyridoula Kontoe, Maja Milanović, Francisco J. Roig, Mirjana Beribaka, Jonica Campolo, Nuria Jiménez-Hernández, Nataša Milošević, Carlos Llorens, Ilias Smyrnioudis, M. Pilar Francino, Nataša Milić, Andriana C. Kaliora, Maria Giovanna Trivella, Mark W. Ruddock, Milica Medić-Stojanoska, Amalia Gastaldelli, John Lamont, Panos Deloukas, George V. Dedoussis, Sophie Visvikis-Siest. Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.683028
164	Hong Yao, Yu-Jie Qiao, Ya-Li Zhao, Xu-Feng Tao, Li-Na Xu, Lian-Hong Yin, Yan Qi, Jin-Yong Peng. Herbal medicines and nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(30): 6890-6905 doi: 10.3748/wjg.v22.i30.6890 Abstract(2524) \| Core Tip(1929) \| Full Article(HTML)(27693) \| Full Article (PDF)-2806K(2101) \| Full Article (Word)-662K(557) \| Audio-102K(39) \| Peer-Review Report-127K(506) \| Answering Reviewers-152K(467) \| Times Cited (123) \| Total Visits (31686) \| Open
165	Shadi Nouri, Mahsa Navari, Fatemeh Zarei, Mitra Rostami, Touraj Mahmoudi, Gholamreza Rezamand, Asadollah Asadi, Hossein Nobakht, Reza Dabiri, Seidamir Pasha Tabaeian. NAMPT gene rs2058539 variant is a risk factor for nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 2024; 70(7) doi: 10.1590/1806-9282.20230188
166	Jiawei Huang, Rumeng Jiang, Yonghong Wang. Effects of the probioticBacillus coagulansBC69 on the metabolic and histological alterations induced by a high-sugar and high-fat diet in C57BL/6J mice. Food & Function 2023; 14(14) doi: 10.1039/D3FO01104F
167	Qian Zhang, Kun Yu, Yazhen Cao, Yanli Luo, Yan Liu, Caiyan Zhao. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3. Life Sciences 2021; 270 doi: 10.1016/j.lfs.2021.119071
168	Tong Yuan, Junjie Liu, Ronghua Zhu, Jiang Li, Zhiyong Huang, Huifang Liang, Haisu Tao, Erlei Zhang. ITLN1, orchestrated by the IFNγ-IRF1 axis, suppresses hepatocellular carcinoma proliferation via ERK1/2 activation. Translational Oncology 2026; 63 doi: 10.1016/j.tranon.2025.102600
169	Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19) doi: 10.3390/ijerph16193570
170	Madeleine Themanns, Kristina M. Mueller, Sonja M. Kessler, Nicole Golob-Schwarzl, Thomas Mohr, Doris Kaltenecker, Jerome Bourgeais, Jamile Paier-Pourani, Katrin Friedbichler, Doris Schneller, Michaela Schlederer, Eva Zebedin-Brandl, Luigi M. Terracciano, Xiaonan Han, Lukas Kenner, Kay-Uwe Wagner, Wolfgang Mikulits, Andrey V. Kozlov, Markus H. Heim, Fabrice Gouilleux, Johannes Haybaeck, Richard Moriggl. Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice. Scientific Reports 2016; 6(1) doi: 10.1038/srep34719
171	Jennifer C Price, Ruibin Wang, Eric C Seaberg, Matthew J Budoff, Lawrence A Kingsley, Frank J Palella , Mallory D Witt, Wendy S Post, Chloe L Thio. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus. Open Forum Infectious Diseases 2017; 4(3) doi: 10.1093/ofid/ofx153
172	Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui. Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease. Livers 2023; 3(4) doi: 10.3390/livers3040045
173	Frédéric Hérault, Magalie Houée-Bigot, Elisabeth Baéza, Olivier Bouchez, Diane Esquerré, Christophe Klopp, Christian Diot. RNA-seq analysis of hepatic gene expression of common Pekin, Muscovy, mule and hinny ducks fed ad libitum or overfed. BMC Genomics 2019; 20(1) doi: 10.1186/s12864-018-5415-1
174	Pervej Alom Barbhuiya, Ameena Ahmed, Partha Pratim Dutta, Saikat Sen, Manash Pratim Pathak. Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices. Current Nutrition Reports 2025; 14(1) doi: 10.1007/s13668-024-00598-w
175	Kasra Pirahesh, Ali Zarrinnia, Leila Nikniaz, Zeinab Nikniaz. Association between sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Preventive Medicine Reports 2025; 50 doi: 10.1016/j.pmedr.2025.102968
176	Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. Journal of Medicinal Food 2019; 22(7) doi: 10.1089/jmf.2018.0020
177	Tharani Senavirathna, Armaghan Shafaei, Ricky Lareu, Lois Balmer. Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Antioxidants 2024; 13(4) doi: 10.3390/antiox13040485
178	Gökay Taylan, Mustafa Ebik, Serdar Solak, Çağlar Kaya, Kenan Yalta. Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 2022; 68(10) doi: 10.1590/1806-9282.20220514
179	Bin Liu, Liping Xiang, Jing Ji, Wei Liu, Ying Chen, Mingfeng Xia, Yuejun Liu, Wenyue Liu, Peiwu Zhu, Yi Jin, Yu Han, Jieli Lu, Xiaoying Li, Minghua Zheng, Yan Lu. Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2. Journal of Clinical Investigation 2021; 131(20) doi: 10.1172/JCI144801
180	Agnieszka Zwolak, Agnieszka Szuster-Ciesielska, Jadwiga Daniluk, Olga Słabczyńska, Martyna Kandefer-Szerszeń, Patricia Aspichueta. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. PLOS ONE 2015; 10(12) doi: 10.1371/journal.pone.0143851
181	Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study. Intestinal Research 2025; 23(1) doi: 10.5217/ir.2023.00078
182	Keke Lu, Jing Wang, Yueyuan Yu, Yikuan Wu, Zhao He. Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice. Food Science & Nutrition 2020; 8(6) doi: 10.1002/fsn3.1445
183	Emily J. Onufer, Yong-Hyun Han, Cathleen Courtney, Allie Steinberger, Maria Tecos, Stephanie Sutton, Anne Sescleifer, Jocelyn Ou, Rafael Sanguinetti Czepielewski, Gwendalyn J. Randolph, Brad W. Warner. Liver injury after small bowel resection is prevented in obesity-resistant 129S1/SvImJ mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(5) doi: 10.1152/ajpgi.00284.2020
184	Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive review. World Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088 Abstract(2056) \| Core Tip(1574) \| Full Article(HTML)(12101) \| Full Article (PDF)-1259K(1178) \| Full Article (Word)-453K(475) \| Peer-Review Report-95K(384) \| Answering Reviewers-70K(390) \| Times Cited (76) \| Total Visits (14905) \| Open
185	Zhihong Ma, Li Chu, Hongying Liu, Jieru Li, Yuanyuan Zhang, Wentai Liu, Jun Dai, Jianfeng Yi, Yue Gao. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway. International Immunopharmacology 2016; 38 doi: 10.1016/j.intimp.2016.06.023
186	Cara Mack, Shikha S. Sundaram. Pediatric Gastrointestinal and Liver Disease. 2021; doi: 10.1016/B978-0-323-67293-1.00073-6
187	Marwan SM Al-Nimer. Is COVID-19-induced liver injury different from other RNA viruses?‎. World Journal of Meta-Analysis 2021; 9(2): 108-127 doi: 10.13105/wjma.v9.i2.108 Abstract(1293) \| Core Tip(1243) \| Full Article(HTML)(3901) \| Full Article (PDF)-6091K(487) \| Full Article (Word)-537K(187) \| Audio-654K(26) \| Peer-Review Report-277K(242) \| Answering Reviewers-35K(248) \| Times Cited (0) \| Total Visits (6150) \| Open
188	Helena A.P. Batatinha, Edson A. Lima, Alexandre A.S. Teixeira, Camila O. Souza, Luana A. Biondo, Loreana S. Silveira, Fabio S. Lira, José C. Rosa Neto. Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR‐α Knockout Mice. Journal of Cellular Physiology 2017; 232(5) doi: 10.1002/jcp.25440
189	Zhengtao Guo, Shengjun Yang, Liwen Qi, Xinming Ma, Yanbo Wang, Bailiang Li, Jian He. Lactobacillus acidophilus KLDS1.0901 ameliorates non-alcoholic fatty liver disease by modulating the tryptophan metabolite indole-3-aldehyde and acting on its receptor AhR. Food & Function 2025; 16(12) doi: 10.1039/D4FO05280C
190	Natalia Muñoz-Durango, Marco Arrese, Alejandra Hernández, Evelyn Jara, Alexis M. Kalergis, Daniel Cabrera. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.563434
191	Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169 doi: 10.1016/j.prostaglandins.2023.106766
192	Mei-Jou Chen, Hong-Nerng Ho. Hepatic manifestations of women with polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology 2016; 37 doi: 10.1016/j.bpobgyn.2016.03.003
193	Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Milena Peruhova, Georgi H. Vasilev, Georgi V. Vasilev, Metodija Sekulovski, Snezhina Lazova, Milena Gulinac, Latchezar Tomov, Antoaneta Mihova, Tsvetelina Velikova. Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases. Gastroenterology Insights 2023; 14(4) doi: 10.3390/gastroent14040041
194	Shuangpeng Cai, Xiaoyu Cheng, Xueyin Pan, Jun Li. Emerging role of exosomes in liver physiology and pathology. Hepatology Research 2017; 47(2) doi: 10.1111/hepr.12794
195	Yaping Wang, Xiaobo Li, Shunlin Ren. Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: From Discovery to Clinical Usage. Metabolites 2020; 11(1) doi: 10.3390/metabo11010009
196	Jae B. Park, Renee Peters, Quynhchi Pham, Thomas T. Y. Wang. Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells. Biomedicines 2020; 8(6) doi: 10.3390/biomedicines8060138
197	Ana Ninić, Marija Zdravković, Vojislav Radosavljević, Vera Gardijan, Lidija Memon, Jelena Vekić, Vesna Spasojević-Kalimanovska. Non-alcoholic fatty liver disease as metabolic consequence of obstructive sleep apnea. Arhiv za farmaciju 2020; 70(6) doi: 10.5937/arhfarm70-27586
198	K.K. Gao, F.-H. Li, Y.-M. Su, J. Wang, X.-M. Yu, L. Ruan, Y.-Z. Zhang. Impact of exercise intervention-based remote monitoring for patients with different grades of non-alcoholic fatty liver disease severity. Science & Sports 2024; 39(1) doi: 10.1016/j.scispo.2022.10.007
199	V. T. Ivashkin, O. M. Drapkina, M. V. Maevskaya, K. L. Raikhelson, S. V. Okovityi, M. S. Zharkova, V. R. Grechishnikova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, P. O. Bogomolov, V. V. Breder, E. V. Vinnitskaya, N. I. Geyvandova, E. V. Golovanova, V. B. Grinevich, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, K. B. Kodzoeva, I. V. Kozlova, K. A. Komshilova, Yu. V. Konev, N. V. Korochanskaya, Yu. V. Kotovskaya, Yu. A. Kravchuk, I. D. Loranskaya, I. V. Maev, A. I. Martynov, S. N. Mekhtiev, E. E. Mishina, M. Yu. Nadinskaia, I. G. Nikitin, M. F. Osipenko, O. D. Ostroumova, Ch. S. Pavlov, N. V. Pogosova, V. G. Radchenko, G. E. Roytberg, R. G. Saifutdinov, A. A. Samsonov, P. V. Seliverstov, S. I. Sitkin, L. V. Tarasova, A. I. Tarzimanova, O. N. Tkacheva, E. I. Tkachenko, E. A. Troshina, S. V. Turkina, Yu. P. Uspenskiy, Yu. A. Fominykh, O. V. Khlynova, Yu. V. Tsyganova, M. Sh. Shamkhalova, O. O. Sharkhun, M. V. Shestakova. Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2025; 35(1) doi: 10.22416/1382-4376-2025-35-1-94-152
200	V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4) doi: 10.22416/1382-4376-2022-32-4-104-140
201	T.S. Sall, E.S. Shcherbakova, S.I. Sitkin, T.Ya. Vakhitov, I.G. Bakulin, E.V. Demyanova. Molecular mechanisms of non-alcoholic fatty liver disease development. Profilakticheskaya meditsina 2021; 24(4) doi: 10.17116/profmed202124041120
202	Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers. International Journal of Molecular Sciences 2022; 23(19) doi: 10.3390/ijms231911188
203	J. E. Nelson, P. Handa, B. Aouizerat, L. Wilson, L. A. Vemulakonda, M. M. Yeh, K. V. Kowdley. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Alimentary Pharmacology & Therapeutics 2016; 44(11-12) doi: 10.1111/apt.13824
204	Rocío Aller, Beatriz Burgueño Gomez, Rebeca Sigüenza, Conrado Fernández-Rodríguez, Natalia Fernández, Beatriz Antolín, Miguel Dur�, María Pina, Sara Lorenzo, Concepción García, Daniel de Luis Román. Comparative study of overweight and obese patients with nonalcoholic fatty liver disease. Revista Española de Enfermedades Digestivas 2019; doi: 10.17235/reed.2019.5926/2018
205	Tamara Bassal, Maamoun Basheer, Mariana Boulos, Nimer Assy. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers. Metabolites 2022; 12(11) doi: 10.3390/metabo12111073
206	Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, Branko Popovic. Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines. Pharmacological Reports 2024; 76(3) doi: 10.1007/s43440-024-00595-4
207	Bassam S. M. Al Kazman, Sadia Rana, Faiza Naseer, Taha Muhammad, Ethar Abdullah Mudhish, Mohammed A. Alshamrani, Omaish S. Alqahtani, Mater H. Mahnashi, Mohammad Saleem. Therapeutic Potential of Conyza bonariensis n‐Hexane Extract in Non‐Alcoholic Fatty Liver Disease: Histological, Biochemical, and In Silico Insights From a High‐Fat Diet Rat Model. Food Science & Nutrition 2025; 13(9) doi: 10.1002/fsn3.70950
208	Jie Wei, Yong-Zhan Zhen, Ju Cui, Fa-Lin He, Tao Shen, Gang Hu, Xiao-Hong Ren, Ya-Jun Lin. Rhein lysinate decreases inflammation and adipose infiltration in KK/HlJ diabetic mice with non-alcoholic fatty liver disease. Archives of Pharmacal Research 2016; 39(7) doi: 10.1007/s12272-016-0770-4
209	Xin Hou, Shi Yin, Ruixue Ren, Siqi Liu, Liang Yong, Yuxiao Liu, Yu Li, Ming‐Hua Zheng, George Kunos, Bin Gao, Hua Wang. Myeloid‐Cell–Specific IL‐6 Signaling Promotes MicroRNA‐223‐Enriched Exosome Production to Attenuate NAFLD‐Associated Fibrosis. Hepatology 2021; 74(1) doi: 10.1002/hep.31658
210	Jennifer C Price, Yifei Ma, Mark H Kuniholm, Adaora A Adimora, Margaret Fischl, Audrey L French, Elizabeth T Golub, Deborah Konkle-Parker, Howard Minkoff, Ighovwerha Ofotokun, Michael Plankey, Anjali Sharma, Phyllis C Tien. Human Immunodeficiency Virus Is Associated With Elevated FibroScan–Aspartate Aminotransferase (FAST) Score. Clinical Infectious Diseases 2022; 75(12) doi: 10.1093/cid/ciac337
211	Christa Buechler, Elisabeth Haberl, Lisa Rein-Fischboeck, Charalampos Aslanidis. Adipokines in Liver Cirrhosis. International Journal of Molecular Sciences 2017; 18(7) doi: 10.3390/ijms18071392
212	Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, Katrin Bose, Peter R. Mertens, Christos Chatzikyrkou. Association of metabolic syndrome and chronic kidney disease. Obesity Reviews 2024; 25(1) doi: 10.1111/obr.13649
213	Rafael Bergesch D’Incao, Cristiane Valle Tovo, Vanessa Suñé Mattevi, Diego Olschowsky Borges, Jane Maria Ulbrich, Gabriela Perdomo Coral, Mauricio Jacques Ramos, Nelson Guardiola Meinhardt. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. Obesity Surgery 2017; 27(8) doi: 10.1007/s11695-017-2627-4
214	Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak. Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review. Phytochemistry Reviews 2024; 23(4) doi: 10.1007/s11101-023-09912-w
215	Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomedicine & Pharmacotherapy 2020; 131 doi: 10.1016/j.biopha.2020.110785
216	Huong Thi Nguyen, Mingkun Gu, Pia Werlinger, Joo-Hyung Cho, Jinhua Cheng, Joo-Won Suh. Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota. International Journal of Molecular Sciences 2022; 23(21) doi: 10.3390/ijms232113436
217	Wen Deng, Zimin Meng, Aitao Sun, Zhihong Yang. Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro study. Cancer Biomarkers 2017; 20(4) doi: 10.3233/CBM-170157
218	Kanika Vashisht, Himanshu Kumar, Swati Rana, Mahendra Singh Ashawat, Shiv Kumar Kushawaha. Rewiring the psoriasis–metabolism axis: therapeutic potential of saroglitazar beyond PPAR modulation. Inflammopharmacology 2026; doi: 10.1007/s10787-026-02413-0
219	Malleswarapu Mahesh, Munugala Bharathi, Mooli Raja Gopal Reddy, Pranati Pappu, Uday Kumar Putcha, Ayyalasomayajula Vajreswari, Shanmugam M Jeyakumar. Carrot juice ingestion attenuates high fructose‐induced circulatory pro‐inflammatory mediators in weanling Wistar rats. Journal of the Science of Food and Agriculture 2017; 97(5) doi: 10.1002/jsfa.7906
220	Xiujuan Wang, Zhangfan Huang, Luming Kong, Hao Lin, Sishun Zhou, Jianrong Ma, Yanbo Zhao, Yunting Zhao, Longhui Liu, Zhongbao Li. Effects of curcumin supplementation in high-fat diet on growth performance, antioxidant capacity and lipid metabolism of spotted sea bass (Lateolabrax maculatus). Fish Physiology and Biochemistry 2026; 52(3) doi: 10.1007/s10695-026-01689-x
221	Yani Ke, Yuyan Pan, Xueru Huang, Xing Bai, Xiaojuan Liu, Mingsi Zhang, Tao Jiang, Guangji Zhang. Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1548924
222	Marcin Kosmalski, Łukasz Mokros, Piotr Kuna, Andrzej Witusik, Tadeusz Pietras. Changes in the immune system – the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease. Central European Journal of Immunology 2018; 43(2) doi: 10.5114/ceji.2018.77395
223	Paulin Bilonda Kabeya. A Comprehensive Guide to Non-alcoholic Fatty Liver Disease. 2025; doi: 10.5772/intechopen.1009971
224	. 2019; doi: 10.70675/6e3b9f25z32efz49c3zab0bza517127ae323
225	Bahareh Amirkalali, Masoud Reza Sohrabi, Ali Esrafily, Mahmoud Jalali, Ali Gholami, Payam Hosseinzadeh, Hossein Keyvani, Farzad Shidfar, Farhad Zamani. Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease. Indian Journal of Medical Research 2018; 147(4) doi: 10.4103/ijmr.IJMR_1065_16
226	Gopanandan Parthasarathy, Xavier Revelo, Harmeet Malhi. Pathogenesis of Nonalcoholic Steatohepatitis: An Overview. Hepatology Communications 2020; 4(4) doi: 10.1002/hep4.1479
227	Yi Hu, Caiyan Lin, Lijie Zhang, Xue Jiang, Huawen Li, Yangzhe Wu. Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma. Advanced Science 2026; 13(44) doi: 10.1002/advs.202523582
228	Jaqueline Pereira Lana, Laís Bhering Martins, Marina Chaves de Oliveira, Zélia Menezes-Garcia, Letícia Tamie Pavia Yamada, Leda Quercia Vieira, Mauro Martins Teixeira, Adaliene Versiani Matos Ferreira. TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions. Applied Physiology, Nutrition, and Metabolism 2016; 41(12) doi: 10.1139/apnm-2016-0265
229	Aamir Bashir, Ajay Duseja, Arka De, Manu Mehta, Pramil Tiwari. Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena. Liver Research 2022; 6(2) doi: 10.1016/j.livres.2022.05.002
230	Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; doi: 10.1007/978-94-007-7742-2_37-1
231	Li Xue, Xiaolan Lu, Juntao He, Ting Zhang, Xiaokang Wu, Yanping Zhang, Ningning Wang, Zhe An, Jiru Xu, Yan Geng. Serum CK 18-M30 reflect liver pathological severity during NAFLD progression in a rat model. Pathology - Research and Practice 2018; 214(11) doi: 10.1016/j.prp.2018.08.016
232	Vera Lede, Andrej Meusel, Antje Garten, Yulia Popkova, Melanie Penke, Christin Franke, Albert Ricken, Angela Schulz, Wieland Kiess, Daniel Huster, Torsten Schöneberg, Jürgen Schiller, Yanqiao Zhang. Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor. PLOS ONE 2017; 12(2) doi: 10.1371/journal.pone.0172000
233	Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
234	Nadella Mounika, Suraj Bhausaheb Mungase, Shivangi Verma, Savneet Kaur, Utpal Jyoti Deka, Tarini Shankar Ghosh, Ramu Adela. Inflammatory Protein Signatures as Predictive Disease-Specific Markers for Non-Alcoholic Steatohepatitis (NASH). Inflammation 2024; 48(1) doi: 10.1007/s10753-024-02035-0
235	Krasimira Aleksandrova, Marta Stelmach-Mardas, Sabrina Schlesinger. Obesity and Cancer. Recent Results in Cancer Research 2016; 208 doi: 10.1007/978-3-319-42542-9_10
236	Atul Goyale, Anjly Jain, Colette Smith, Margarita Papatheodoridi, Marta Guerrero Misas, Davide Roccarina, Laura Iogna Prat, Dimitri P. Mikhailidis, Devaki Nair, Emmanuel Tsochatzis, Pavel Strnad. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. PLOS ONE 2021; 16(11) doi: 10.1371/journal.pone.0260313
237	Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim. Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/7653689
238	Xu Zhang, Xuetao Ji, Qian Wang, John Zhong Li. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein & Cell 2018; 9(2) doi: 10.1007/s13238-017-0436-0
239	Mohammad Shafi Kuchay, Narendra Singh Choudhary, Sunil Kumar Mishra. Pathophysiological mechanisms underlying MAFLD. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(6) doi: 10.1016/j.dsx.2020.09.026
240	Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70721
241	Veeravich Jaruvongvanich, Anawin Sanguankeo, Tanawan Riangwiwat, Sikarin Upala. Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Annals of Hepatology 2017; 16(3) doi: 10.5604/01.3001.0009.8593
242	Dongxu Wang, Qiang Gao, Taotao Wang, Zhipeng Kan, Xin Li, Lizhen Hu, Chuan-yi Peng, Frank Qian, Yijun Wang, Daniel Granato. Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activation. Food Research International 2020; 127 doi: 10.1016/j.foodres.2019.108628
243	Kui Peng, Lin Lin, Zhengyi Wang, Lin Ding, Ya Huang, Po Wang, Yu Xu, Jieli Lu, Min Xu, Yufang Bi, Weiqing Wang, Yuhong Chen, Guang Ning. Short sleep duration and longer daytime napping are associated with non‐alcoholic fatty liver disease in Chinese adults. Journal of Diabetes 2017; 9(9) doi: 10.1111/1753-0407.12489
244	Paloma Gallego, Amparo Luque-Sierra, Gonzalo Falcon, Pilar Carbonero, Lourdes Grande, Juan D. Bautista, Franz Martín, José A. Del Campo. White Button Mushroom Extracts Modulate Hepatic Fibrosis Progression, Inflammation, and Oxidative Stress In Vitro and in LDLR-/- Mice. Foods 2021; 10(8) doi: 10.3390/foods10081788
245	Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas V. Paul, Nihal Thomas, Sharon R. Lewin. A gathering storm. AIDS 2019; 33(7) doi: 10.1097/QAD.0000000000002161
246	I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Proceedings of the Nutrition Society 2016; 75(1) doi: 10.1017/S0029665115004218
247	Maria Jimenez Ramos, Lucia Bandiera, Filippo Menolascina, Jonathan Andrew Fallowfield. In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications. iScience 2022; 25(1) doi: 10.1016/j.isci.2021.103549
248	Mingjun Tan, Rami Mosaoa, Garrett T. Graham, Anna Kasprzyk-Pawelec, Shreyas Gadre, Erika Parasido, Olga Catalina-Rodriguez, Patricia Foley, Giuseppe Giaccone, Amrita Cheema, Bhaskar Kallakury, Chris Albanese, Chunling Yi, Maria Laura Avantaggiati. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. Cell Death & Differentiation 2020; 27(7) doi: 10.1038/s41418-020-0491-6
249	Ekrem Aksu, Abdullah Sokmen, Murat Ispiroglu, Kadir Gisi, Enes Celik, Ahmet Cagri Aykan. Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease. Kardiologiia 2021; 61(5) doi: 10.18087/cardio.2021.5.n1416
250	AhmedM M. Mahmouda, NohaA.-R A. El-Hagag, HusseinI El-Bitar, Abdel-HalimM Afifi. Potential protective effect of curcumin in high-fat diet-induced nonalcoholic fatty liver disease in rats. Journal of Current Medical Research and Practice 2021; 6(1) doi: 10.4103/JCMRP.JCMRP_37_20
251	Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Angiology 2022; 73(8) doi: 10.1177/00033197221091317
252	Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease. PLOS ONE 2020; 15(2) doi: 10.1371/journal.pone.0219412
253	Mohamed M.A. Hussein, Hussein I. El-Belbasi, Mohamed A. Morsy, Islam M. Saadeldin, Ghedeir M. Alshammari. The synergistic effect of fenretinide and metformin to achieve a decrease in insulin resistance and inflammatory mediators: an in vivo study. All Life 2020; 13(1) doi: 10.1080/26895293.2020.1732483
254	Nadia Panera, Barbara Barbaro, Claudia Della Corte, Antonella Mosca, Valerio Nobili, Anna Alisi. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease. Nutrition Research 2018; 58 doi: 10.1016/j.nutres.2018.05.002
255	M Pallavi, MM Suchitra, P.V.L.N Srinivasa Rao. Role of adipokines in the pathogenesis of nonalcoholic fatty liver disease. Journal of Clinical and Scientific Research 2015; 4(1) doi: 10.15380/2277-5706.JCSR.14.072
256	Peter Müller, Marie Messmer, Monika Bayer, Josef M. Pfeilschifter, Edith Hintermann, Urs Christen. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model. Journal of Autoimmunity 2016; 69 doi: 10.1016/j.jaut.2016.02.007
257	Min-Gyung Kang, Hee Jae Lee, Jae-Young Cho, Kanghwa Kim, Soo Jin Yang, Doman Kim. Anti-inflammatory effects of sucrose-derived oligosaccharides produced by a constitutive mutant L. mesenteroides B-512FMCM dextransucrase in high fat diet-fed mice. Biochemical and Biophysical Research Communications 2016; 477(3) doi: 10.1016/j.bbrc.2016.06.102
258	Helda Tutunchi, Farideh Zolrahim, Mahlagha Nikbaf-Shandiz, Fatemeh Naeini, Alireza Ostadrahimi, Sina Naghshi, Reza Salek, Farzad Najafipour. Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1144550
259	Chen Shen, Jin Hong Chen, Ha Ram Oh, Ji Hyun Park. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36. FEBS Letters 2021; 595(19) doi: 10.1002/1873-3468.14193
260	Aneeqa Imtiaz, Muhammad Talha Bin Tahir, Minmeng Zhao, Daoqing Gong, Jing Ge, Tuoyu Geng. Non-Alcoholic Fatty Liver Disease in Poultry: Risk Factors, Mechanism of Development, and Emerging Strategies. International Journal of Molecular Sciences 2025; 26(17) doi: 10.3390/ijms26178460
261	Like Xu, Weiru Liu, Xiaoqin Wu, Tingting Chen, Yong Gao, Jiawen Huang, Zhuohui Luo. Citri Reticulatae Pericarpium improves obesity in OVX mice by regulating the gut microbiota and suppressing appetite. Food & Function 2025; 16(24) doi: 10.1039/D5FO03974F
262	F. Hérault, C. Duby, E. Baéza, C. Diot. Adipogenic genes expression in relation to hepatic steatosis in the liver of two duck species. Animal 2018; 12(12) doi: 10.1017/S1751731118000897
263	Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of Diabetes. Clinical Gastroenterology 2018; doi: 10.1007/978-3-319-75856-5_21
264	Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky. Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2020; 26(2) doi: 10.3350/cmh.2019.0074
265	Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Advances in Nutrition 2021; 12(2) doi: 10.1093/advances/nmaa106
266	Jacob Beiriger, Kashyap Chauhan, Adnan Khan, Taha Shahzad, Natalia Salinas Parra, Peter Zhang, Sarah Chen, Anh Nguyen, Brian Yan, John Bruckbauer, Dina Halegoua-DeMarzio. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies. Livers 2023; 3(4) doi: 10.3390/livers3040042
267	Anna Tomasiewicz, Tomasz Targowski, Sebastian Makuch, Jacek Polański, Wojciech Tański. The Relationship Between Bioelectrical Impedance Analysis Parameters and Laboratory Biomarkers in an Elderly Polish Cohort: A Cross-Sectional Study. Nutrients 2025; 17(24) doi: 10.3390/nu17243843
268	Ana Elenka Ortíz-Reyes, C. Marissa Calderón-Torres. INCREMENTO DE LA EXPRESIÓN DE TLR4 Y EFECTO ANTIOXIDANTE DEL ÁCIDO ACETILSALICÍLICO EN CONEJOS CON DIETA ALTA EN GRASAS. RESPYN Revista Salud Pública y Nutrición 2017; 16(2) doi: 10.29105/respyn16.2-1
269	Johanna Heitmann, Verena G. Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan. Nicht‐alkoholische Fettlebererkrankung und Psoriasis – besteht ein gemeinsames proinflammatorisches Netzwerk?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021; 19(4) doi: 10.1111/ddg.14425_g
270	Xingcen Chen, Ruyi Peng, Dongzi Peng, Jia Xiao, Deliang Liu, Rong Li. An update: is there a relationship between H. pylori infection and nonalcoholic fatty liver disease? why is this subject of interest?. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1282956
271	Pavel Kraml. Lipid-lowering therapy in selected specific groups of patients. Medicína pro praxi 2020; 17(3) doi: 10.36290/med.2020.029
272	Yuanyuan WU, Jingwen ZHOU, Xinchen ZUO, Yufeng KUANG, Lixia SUN, Xiaolong ZHANG. Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-κB/NLRP3 signaling pathway. Chinese Journal of Natural Medicines 2024; 22(3) doi: 10.1016/S1875-5364(24)60595-9
273	Fani-Niki Varra, Michail Varras, Viktoria-Konstantina Varra, Panagiotis Theodosis‑Nobelos. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review). Molecular Medicine Reports 2024; 29(6) doi: 10.3892/mmr.2024.13219
274	Kareem M Abdelraheem, Nahla N Younis, Mohamed A Shaheen, Sahar E Elswefy, Sousou I Ali. Raspberry ketone improves non-alcoholic fatty liver disease induced in rats by modulating sphingosine kinase/sphingosine-1-phosphate and toll-like receptor 4 pathways. Journal of Pharmacy and Pharmacology 2023; 75(7) doi: 10.1093/jpp/rgad044
275	Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances. The Journal of Pathology 2017; 241(1) doi: 10.1002/path.4829
276	Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. International Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
277	Patrícia de Castro-de-Paiva, Thatiany de Souza Marinho, Carlos Alberto Mandarim-de-Lacerda, Marcia Barbosa Aguila. Intermittent fasting, high-intensity interval training, or a combination of both have beneficial effects in obese mice with nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry 2022; 104 doi: 10.1016/j.jnutbio.2022.108997
278	Maximilian J. Ganz, Sascha T. Bender, Christian Gross, Katrin Bose, Peter R. Mertens, Florian G. Scurt. Metabolisches Syndrom und Nierenkrankheiten. Die Nephrologie 2022; 17(5) doi: 10.1007/s11560-022-00595-6
279	J.E. Davis, J. Cain, C. Small, D.B. Hales. Therapeutic effect of flax-based diets on fatty liver in aged laying hens. Poultry Science 2016; 95(11) doi: 10.3382/ps/pew160
280	Bai Ruiyang, Adriana Panayi, Wu Ruifang, Zhang Peng, Fu Siqi. Adiponectin in psoriasis and its comorbidities: a review. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01510-z
281	Yohei Owada, Takafumi Tamura, Tomohito Tanoi, Yusuke Ozawa, Yoshio Shimizu, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Toshiya Matsukawa, Hiroko Isoda, Nobuhiro Ohkohchi. Novel non‐alcoholic steatohepatitis model with histopathological and insulin‐resistant features. Pathology International 2018; 68(1) doi: 10.1111/pin.12612
282	Parichehr Amiri, Sara Arefhosseini, Farnush Bakhshimoghaddam, Hannah Jamshidi Gurvan, Seyed Ahmad Hosseini. Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1037696